Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 25,332
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A
roaringcharts
roaringcharts Feb. 3 at 6:44 PM
$PLYX PARAMUS, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces it will be presenting a late-breaking abstract on new data for PLX-200, an investigational therapy for the treatment of Krabbe disease (globoid cell leukodystrophy) at the 22nd Annual WORLDSymposium™, held February 2-6, 2026 in San Diego, Calif. These data support the continued advancement on progressing the launch of the SOTERIA trial, a Phase 2, open-label, single arm trial intended to assess the safety, tolerability, and clinical activity of PLX-200, in CLN2, CLN3, Krabbe disease, and Sandhoff disease.
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 6:42 PM
$PLYX legit man out of paramus nj. Elitist town
0 · Reply
tradeviews99
tradeviews99 Feb. 3 at 6:39 PM
$PLYX Good luck 😊. Worth checking About Us page ..
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 6:01 PM
$PLYX i see it early quietly
0 · Reply
CapitalGuidanceFramework
CapitalGuidanceFramework Feb. 3 at 4:58 PM
$PLYX $AC.TSX International exposure
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 4:40 PM
$PLYX missing a 0
0 · Reply
Scrappy_Coco
Scrappy_Coco Feb. 3 at 4:37 PM
$PLYX looks good could goto 30000000
0 · Reply
mazz66
mazz66 Feb. 3 at 4:03 PM
$PLYX looks good could go to 3000000
0 · Reply
ciggycapital
ciggycapital Feb. 3 at 3:52 PM
$PLYX looks good could go to 300
0 · Reply
Hadaddy1211
Hadaddy1211 Feb. 3 at 3:37 PM
$PLYX looks good, could go to 200
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 6:44 PM
$PLYX PARAMUS, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces it will be presenting a late-breaking abstract on new data for PLX-200, an investigational therapy for the treatment of Krabbe disease (globoid cell leukodystrophy) at the 22nd Annual WORLDSymposium™, held February 2-6, 2026 in San Diego, Calif. These data support the continued advancement on progressing the launch of the SOTERIA trial, a Phase 2, open-label, single arm trial intended to assess the safety, tolerability, and clinical activity of PLX-200, in CLN2, CLN3, Krabbe disease, and Sandhoff disease.
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 6:42 PM
$PLYX legit man out of paramus nj. Elitist town
0 · Reply
tradeviews99
tradeviews99 Feb. 3 at 6:39 PM
$PLYX Good luck 😊. Worth checking About Us page ..
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 6:01 PM
$PLYX i see it early quietly
0 · Reply
CapitalGuidanceFramework
CapitalGuidanceFramework Feb. 3 at 4:58 PM
$PLYX $AC.TSX International exposure
0 · Reply
roaringcharts
roaringcharts Feb. 3 at 4:40 PM
$PLYX missing a 0
0 · Reply
Scrappy_Coco
Scrappy_Coco Feb. 3 at 4:37 PM
$PLYX looks good could goto 30000000
0 · Reply
mazz66
mazz66 Feb. 3 at 4:03 PM
$PLYX looks good could go to 3000000
0 · Reply
ciggycapital
ciggycapital Feb. 3 at 3:52 PM
$PLYX looks good could go to 300
0 · Reply
Hadaddy1211
Hadaddy1211 Feb. 3 at 3:37 PM
$PLYX looks good, could go to 200
0 · Reply
SnackBandit34
SnackBandit34 Feb. 2 at 7:38 PM
$PLYX Looks good could go to 100
1 · Reply
PaulLaurent
PaulLaurent Feb. 2 at 7:08 PM
🚨 RTH Halt Watch — February 2, 2026 These names halted during RTH. They can get interesting again into AH. In AH, be ready for lightning exits—some trades may last 20–30 seconds. Some won’t move at all; stay nimble and manage risk. $PLYX — Direct listing biotech (lysosomal disorders). ~47.34M shares registered for resale; FY24 rev $0; net loss ~$30.4M (vs. ~$3.8M FY23). Treat like a $VHUB -style debut: thin book, halt-prone, big wicks. $PBM — Post-RS nano-float: shs out ≈ 0.05M, float ≈ 0.04M, short float ~26.9% (see pic). Micro supply = air pockets both ways; liquidity can vanish fast. $JLHL — Pure range/halt tape. We caught a +54.4% leg earlier; expect whips and volatility expansions. Use hard stops and scale out. $ELPW — Recently priced ~$7.6M offering. Classic “offer reclaim or fade” setup—watch the offering level as a pivot and borrow availability. Playbook: tiny size, take quick partials, avoid chasing into second/third consecutive halts. Not financial advice.
0 · Reply
Hadaddy1211
Hadaddy1211 Feb. 2 at 5:10 PM
$PLYX keep a lookout for this!! Once price settles! $ELPW $PBM
1 · Reply
IPOtweet
IPOtweet Feb. 2 at 2:55 PM
Micro-cap Polaryx Therapeutics to trade on the Nasdaq today via direct listing $PLYX $IPO #IPO https://zpr.io/BDcmkQMREvRD
0 · Reply
PinoDivino
PinoDivino Feb. 2 at 2:38 PM
$PLYX when will a price show
1 · Reply